ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 709969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 709969; 2) Community: the network communities that were significantly associated with the response to NSC 709969; 3) Molecule: the relationships between components within communities and NSC 709969; 4) MDR: the compounds that were significantly associated with the NSC 709969.

NSC Compound Enrichment Correlation
NSC 763232 Null 0.0102077332082017 0.22001211
NSC 77039 Null 0.0102077332082017 0.24180738
NSC 87500 Solacongestidine 0.0102077332082017 0.30847236
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0102962192514438 0.2364157
NSC 732851 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene 0.0102962192514438 0.45685177
NSC 734562 6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride 0.0102962192514438 0.17643036
NSC 736164 pyrazoline derivative 0.0102962192514438 0.43897267
NSC 741942 Null 0.0102962192514438 0.27064069
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0102962192514438 0.37373439
NSC 136468 Null 0.0102962192514439 0.43230281
Total:184  Current:58    [First] [Prev] [Next] [Last]